Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Vyndaqel
Vyndaqel
Pfizer escapes proposed class action lawsuit over patient copay assistance
Fierce Pharma
Fri, 04/7/23 - 01:52 pm
Pfizer
legal
copay asssistance programs
Vyndaqel
Vyndamax
U.S. Supreme Court rebuffs Pfizer plan to help patients pay for heart medication
Reuters
Tue, 01/10/23 - 10:59 am
Pfizer
Supreme Court
Medicare
kickbacks
Vyndaqel
Vyndamax
Pfizer musters J&J, PhRMA's support in closely watched Vyndaqel copay assistance case at Supreme Court
Fierce Pharma
Tue, 11/15/22 - 10:32 am
Pfizer
JNJ
copay asssistance programs
kickbacks
Vyndaqel
Vyndamax
Supreme Court
Pfizer takes Vyndaqel copay fight to Supreme Court, decrying 'staggeringly overbroad' anti-kickback rule
Fierce Pharma
Mon, 10/17/22 - 11:31 pm
Pfizer
Supreme Court
kickbakcs
tafamidis
copays
Vyndaqel
Pfizer loses court battle to keep its Vyndaqel copay assistance for Medicare patients—again
Fierce Pharma
Tue, 07/26/22 - 05:23 pm
Pfizer
copay asssistance programs
Vyndaqel
Medicare
kickbacks
Bridgebio sets its heart on besting Pfizer
EP Vantage
Fri, 12/3/21 - 10:31 am
BridgeBio
Pfizer
acoramidis
Vyndaqel
amyloidosis
transthyretin amyloid cardiomyopathy
Pfizer prohibited from subsidizing its heart drugs for Medicare patients
Beckers Hospital Review
Mon, 10/4/21 - 11:12 pm
Pfizer
Medicare
Vyndamax
Vyndaqel
Pfizer victory in Vyndaqel copay lawsuit could kneecap the government's only control on prices, lawyer warns
Fierce Pharma
Wed, 07/7/21 - 12:06 pm
Pfizer
Vyndaqel
copays
legal
Pfizer sues for U.S. permission to assist patients needing expensive heart drugs
Reuters
Fri, 06/26/20 - 07:45 pm
Pfizer
federal government
Medicare
Vyndaqel
Vyndamax
Pfizer's blockbuster-to-be Vyndaqel is too costly for heart patients, study suggests
Fierce Pharma
Fri, 06/19/20 - 12:10 pm
Pfizer
tafamidis
Vyndaqel
drug pricing
Pfizer Gains European Approval for Amyloidosis Drug Vyndaqel
Fierce Biotech
Tue, 02/18/20 - 08:30 pm
Europe
Pfizer
transthyretin amyloidosis
ATTR-CM
Vyndaqel
Pfizer's heart med Vyndaqel off and running thanks to diagnosis push: execs
Fierce Pharma
Tue, 01/28/20 - 11:34 pm
Pfizer
Vyndaqel
ATTR-CM
Watch Out, Pfizer: This $2 Billion Biotech Is Coming for You
Motley Fool
Sat, 11/23/19 - 04:11 pm
Pfizer
Vyndaqel
ATTR-CM
Eidos Therapeutics
AG10
These Biotechs Were Focused on One Line on Pfizer’s Earnings Report
Motley Fool
Thu, 10/31/19 - 11:51 pm
Pfizer
Vyndaqel
Alnylam
Akcea Therapeutics
Ionis Pharmaceuticals
Eidos Therapeutics
Pfizer's heart drug impresses with fast US launch
Biopharma Dive
Tue, 10/29/19 - 10:50 pm
Pfizer
drug launches
Vyndaqel
ATTR-CM
Pfizer's Vyndaqel franchise, buoyed by diagnoses, is poised for 'a decisive beat': analyst
Fierce Pharma
Fri, 10/18/19 - 07:45 pm
Pfizer
tafamidis
FDA
Vyndaqel
Alnylam
Ionis
ATTR amyloidosis
5 Biggest New Drugs Approved in 2019 So Far
Motley Fool
Tue, 08/13/19 - 11:43 am
drug approvals
FDA
AbbVie
JNJ
Novartis
Pfizer
Skyrizi
psoriasis
Vyndaqel
Zolgensma
SMA
Mayzent
multiple sclerosis
Balversa
metastatic bladder cancer
Pfizer's new Vyndaqel franchise worth far more than $1.5B, analyst figures
Fierce Pharma
Thu, 05/30/19 - 12:36 pm
Pfizer
tafamdis
ATTR
Vyndaqel
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
Xconomy
Mon, 05/6/19 - 10:54 am
FDA
Pfizer
tafamidis
Vyndaqel
Vyndamax
ATTR
Alnylam
Akcea
6 Things Alnylam Investors Need to Know About Pfizer's Next Blockbuster Drug
Motley Fool
Tue, 08/28/18 - 10:18 am
Alnylam
Onpattro
Pfizer
ATTR amyloidosis
tafamidis
Vyndaqel
Pages
1
2
next ›
last »